<?xml version="1.0" encoding="UTF-8"?>
<rss version="2.0"
	xmlns:content="http://purl.org/rss/1.0/modules/content/"
	xmlns:wfw="http://wellformedweb.org/CommentAPI/"
	xmlns:dc="http://purl.org/dc/elements/1.1/"
	xmlns:atom="http://www.w3.org/2005/Atom"
	xmlns:sy="http://purl.org/rss/1.0/modules/syndication/"
	xmlns:slash="http://purl.org/rss/1.0/modules/slash/"
	>

<channel>
	<title>The Soul of Biotech &#187; regulations</title>
	<atom:link href="http://www.thesoulofbiotech.com/category/regulations/feed/" rel="self" type="application/rss+xml" />
	<link>http://www.thesoulofbiotech.com</link>
	<description>Laughter is the best medicine -- but let's cure cancer anyway.</description>
	<lastBuildDate>Fri, 10 Jul 2009 18:46:53 +0000</lastBuildDate>
	<language>en</language>
	<sy:updatePeriod>hourly</sy:updatePeriod>
	<sy:updateFrequency>1</sy:updateFrequency>
	<generator>http://wordpress.org/?v=abc</generator>
		<item>
		<title>What Are Follow-on Biologics? Will They Really Save Us Billions Of Dollars?</title>
		<link>http://www.thesoulofbiotech.com/2009/06/29/what-are-follow-on-biologics-will-they-really-save-us-billions-of-dollars/</link>
		<comments>http://www.thesoulofbiotech.com/2009/06/29/what-are-follow-on-biologics-will-they-really-save-us-billions-of-dollars/#comments</comments>
		<pubDate>Mon, 29 Jun 2009 20:27:18 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[follow-on biologics]]></category>
		<category><![CDATA[regulations]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=175</guid>
		<description><![CDATA[This post originally appeared here as a guest post on the Better Health blog network. It has since also appeared here on the I Am Biotech blog. Much has been made of the recent pressure on the FDA to create a pathway for follow-on biologics. On June 9, 2009, Rep. Henry Waxman, chair of the [...]]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/06/29/what-are-follow-on-biologics-will-they-really-save-us-billions-of-dollars/feed/</wfw:commentRss>
		<slash:comments>18</slash:comments>
		</item>
		<item>
		<title>My BIL &#8217;09 talk video is online!</title>
		<link>http://www.thesoulofbiotech.com/2009/03/10/my-bil-09-talk-video-is-online/</link>
		<comments>http://www.thesoulofbiotech.com/2009/03/10/my-bil-09-talk-video-is-online/#comments</comments>
		<pubDate>Wed, 11 Mar 2009 06:39:17 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[bil]]></category>
		<category><![CDATA[conference]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[regulations]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=131</guid>
		<description><![CDATA[The Promise and the Peril of Personalized Medicine from Jeriaska on Vimeo. Many thanks to Drew Reynolds for taping this and editing together this abbreviated version. The uncut talk was about ten minutes long &#8212; I started out explaining what treatment-response biomarkers are, and how they can improve patient outcomes and save money for payors.]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/03/10/my-bil-09-talk-video-is-online/feed/</wfw:commentRss>
		<slash:comments>6</slash:comments>
		</item>
		<item>
		<title>EEOC invites comment on GINA</title>
		<link>http://www.thesoulofbiotech.com/2009/02/28/eeoc-invites-comment-on-gina/</link>
		<comments>http://www.thesoulofbiotech.com/2009/02/28/eeoc-invites-comment-on-gina/#comments</comments>
		<pubDate>Sat, 28 Feb 2009 18:22:31 +0000</pubDate>
		<dc:creator>Jonathan</dc:creator>
				<category><![CDATA[genetics]]></category>
		<category><![CDATA[pharmacogenomics]]></category>
		<category><![CDATA[regulations]]></category>

		<guid isPermaLink="false">http://www.thesoulofbiotech.com/?p=125</guid>
		<description><![CDATA[The EEOC has invited the public to comment on the Genetic Information Nondiscrimination Act (GINA). GINA was passed in the spring of 2008 as a way to bar employers from discriminating against employees on the basis of genetic information. GINA also prevents healthcare insurers from discriminating based on genetic information. GINA is an important step [...]]]></description>
		<wfw:commentRss>http://www.thesoulofbiotech.com/2009/02/28/eeoc-invites-comment-on-gina/feed/</wfw:commentRss>
		<slash:comments>1</slash:comments>
		</item>
	</channel>
</rss>

<!-- Dynamic Page Served (once) in 0.535 seconds -->
